Announcement on behalf of APBio’s resolution to lift non-competition restrictions for directors at 2022 extraordinary Shareholders’ Meeting

1.Date of the shareholders’ meeting resolution:2022/11/09
2.Name and title of the managerial officer with permission to engage in competitive conduct:
Director Frank Chen
Director Jeng Her
Director Ming-Tain Lai
Director Audrey Tseng
Director Ivy Lin
3.Items of competitive conduct in which the officer is permitted to engage:Scope of business similar to that of AP Biosciences.
4.Period of permission to engage in the competitive conduct:Duration of serving as a director of AP Biosciences.
5.Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act):The resolution was adopted by a large majority of two thirds of the shareholders of whom have voting rights and were present at the extraordinary General Shareholders’ Meeting.
6.If the permitted competitive conduct belongs to the operator of a mainland China enterprise, the name and title of the directors (if it is not the operator of a mainland China enterprise, please enter “N/A” below): N/A
7.Company name of the mainland China enterprise and the officer’s position in the enterprise: N/A
8.Address of the mainland China enterprise: N/A
9.Operations of the mainland China enterprise: N/A
10.Impact on the company’s finance and business: N/A
11.If the directors have invested in the mainland China enterprise, the monetary amount of the investment and their shareholding ratio: N/A
12.Any other matters that need to be specified:None